Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.
about
Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors.Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells.Management of drug interaction between posaconazole and sirolimus in patients who undergo hematopoietic stem cell transplant.
P2860
Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@ast
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@en
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@nl
type
label
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@ast
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@en
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@nl
prefLabel
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@ast
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@en
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@nl
P2093
P2860
P1476
Sirolimus pharmacokinetics in ...... od and marrow transplantation.
@en
P2093
Donna A Wall
Kelong Han
Michael A Pulsipher
Nancy Bunin
Rakesh K Goyal
Raman Venkataramanan
Sripal R Mada
Stephan A Grupp
P2860
P304
P356
10.1016/J.BBMT.2012.12.015
P577
2012-12-21T00:00:00Z